Spark Therapeutics, home of the biggest ever venture-backed exit in Philadelphia, will name a new chief executive officer, as its current and only CEO Jeffery Marrazzo announced recently that he’ll be stepping down April 1.
The gene therapy company, a publicly traded spinout of Children’s Hospital of Philadelphia, was cofounded by Marrazzo in 2013. Chief Operating Officer Ron Philip will succeed Marrazzo.
“When I think about Spark’s future, I’ve long viewed Ron as the next person to take over at the helm — not only is he a steadfast leader, he’s been instrumental in developing Spark’s gene therapy pipeline and has a deep understanding of Spark’s unique culture,” Marrazzo said in a statement. “I am incredibly proud of what we’ve built at Spark: from my first meetings in 2011, when the company was merely an idea, to now as the gene therapy center of excellence at one of the largest healthcare companies in the world.”
READ FULL ARTICLE HERE
